跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
DESVENLAFAXINE SANDOZ PHARMA desvenlafaxine 100 mg extended release tablet blister pack - TGA Drug Approval Details
Approvals
/
TGA
/
DESVENLAFAXINE SANDOZ PHARMA desvenlafaxine 100 mg extended release tablet blister pack
Approved
STANDARD
DESVENLAFAXINE SANDOZ PHARMA desvenlafaxine 100 mg extended release tablet blister pack
Sandoz Pty Ltd
🇦🇺 Therapeutic Goods Administration
Approval Date
Dec 9, 2025
Approval ID
942491ef54d1b546
Company
Sandoz Pty Ltd
Type
Standard
Approval Details
Approval Id
942491ef54d1b546
Product Name
DESVENLAFAXINE SANDOZ PHARMA desvenlafaxine 100 mg extended release tablet blister pack
Artg Id
425293
Artg Name
DESVENLAFAXINE SANDOZ PHARMA desvenlafaxine 100 mg extended release tablet blister pack
Sponsor
Sandoz Pty Ltd
Company Detail Path
/organization/sandoz-pty-ltd
Artg Date
2023-12-11
Registration Type
Medicine
Therapeutic Good Type
Medicine
Licence Status
A
Licence Category
RE
Approved
Quick Info
Agency
TGA
Country
🇦🇺
Approval Date
Dec 9, 2025
Approval ID
942491ef54d1b546
Type
Standard
Back to TGA Approvals
